Biosynthesis of Stilbene Compounds in Engineered E. coli
Author Information
Author(s): Kevin T. Watts, Pyung C. Lee, Claudia Schmidt-Dannert
Primary Institution: University of Minnesota
Hypothesis
Can engineered E. coli produce stilbene compounds from phenylpropionic acid precursors?
Conclusion
Recombinant E. coli can efficiently convert phenylpropionic acids into stilbene compounds like resveratrol and piceatannol.
Supporting Evidence
- Resveratrol was produced at a level of over 100 mg/L in E. coli.
- Piceatannol was produced at levels around 13 mg/L.
- Ferulic acid did not yield the expected stilbene product, indicating limitations in the pathway.
Takeaway
Scientists made a type of medicine called stilbene in bacteria instead of plants, which is usually hard to do.
Methodology
The study involved cloning plant genes into E. coli to create a pathway for stilbene biosynthesis and testing various phenylpropionic acids as substrates.
Limitations
The conversion yield of resveratrol was less than 50%, and ferulic acid was not converted to the expected stilbene product.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website